Heraeus Kulzer filed another lawsuit against Zimmer Biomet (NYSE:ZBH) over bone cement trade secrets Biomet allegedly stole from the German dental company, according to a regulatory filing. Hanau, Germany-based Heraeus sued Biomet back in 2008, alleging that Biomet misappropriated trade secrets when developing its Refobacin and Biomet bone cements. In June 2014, a German appeals court enjoined Biomet […]
BioTime pulls in $20m, inks deal with Heraeus Medical
Regenerative medicine company BioTime said this week it raised $20 million in a closed round and it inked a development and licensing deal between its subsidiary Orthocyte and orthobiological-focused Heraeus Medical. BioTime and its subsidiaries develop regenerative technologies around pluripotent stem cells and cell-based therapies. Alameda, Calif.-based BioTime said today it closed a direct offering of […]
ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A
Biomet settles with patent troll, loses European bone cement suit
Biomet said this week that it settled a portion of a patent infringement case with a notorious patent troll and lost a trade secrets theft lawsuit brought in Germany over some of its bone cements.
